On February 20, 2019, Shenzhen Municipal Market Supervision and Administration Bureau issued Shenzhen City Supervision [2019] No. 41 document, Shenzhen Beike Biotechnology Co., Ltd. (hereinafter referred to as: Beike Biotechnology) won the title of “R&D and Standardization Simultaneous Demonstration Enterprise”.
This honor represents the recognition of Beike Biotech in the research and development and standardization direction by various municipal departments. It marks that Beike Biotech, as a leader in the cell technology industry, has added a new step to the standardization construction of the industry!
The review of “Synchronized R&D and Standardization Demonstration Enterprises” has been carried out for two consecutive years since 2017. It was established in accordance with the deployment of the municipal government’s “Shenzhen Standards Internationalized Innovative City Demonstration Creation Work Plan” and the standard requirements of the “Evaluation Guide for Synchronous R&D and Standardization Demonstration Enterprises”. It is an important link in building Shenzhen quality and Shenzhen standards. It aims to evaluate the effectiveness of the simultaneous construction of enterprise R&D and standardization, cultivate and identify a group of demonstration enterprises for the simultaneous construction of R&D and standardization, and give full play to the demonstration and leading effect of benchmark enterprises.
Cell preparation technology is a complex high-tech, and standardization work is relatively weak. As a pathfinder in this field, Beike Biotech has been committed to the development of industry standardization:
In 2011, Beike Biotech overcame many difficulties and took the lead in introducing international AABB certification;
In 2016, Beike Biotech took the lead in drafting and compiling Shenzhen local standards: “Cell Preparation Center Construction and Management Specifications” and “Comprehensive Cell Bank Setup and Management Specifications”;
In 2016, Beike Biotech participated in the formulation of the “Self-regulatory Specifications for Quality Management of Preparation of Stem Cell Preparations” and “Self-Regulatory Specifications for Quality Management of Preparation of Immune Cell Preparations”;
In 2018, Beike Biotech took the lead in applying for the title of “Cell Preparation Engineer” from the Bureau of Human Resources and Social Security;
In 2018, Beike Biotech took the lead in introducing third-party quality testing.
……
Beike Biotechnology is an early national high-tech enterprise specializing in the clinical transformation and technical services of biotherapeutic technologies in strategic emerging industries in my country. It attaches great importance to research and development and standardization management, and promotes and ensures the simultaneous development of technology research and development, standard innovation, and industrialization from aspects such as organizational structure, budget, and management systems.
This time, Beike Biotech successfully won the title of “R&D and Standardization Simultaneous Demonstration Enterprise” after going through the procedures of self-evaluation, application, defense, expert review, and public announcement. This is the recognition of the municipal government and society for Beike Biotech’s standardization and R&D work!
Beike Biotechnology, as a pathfinder in this field, will continue to increase investment in R&D and standardization construction, promote more efficient development of enterprises, bring better services to users, and contribute more to the standardization construction of the country and industry!